Novo Nordisk launches a 15 billion Danish kroner stock repurchase program.

On February 3rd local time, Novo Nordisk announced that at the annual general meeting on March 26, 2026, the board of directors will propose a year-end dividend of 7.95 Danish Kroner per share for 2025, bringing the total expected dividend for 2025 to 11.70 Danish Kroner. The board of directors has decided to launch a new share buyback program with a maximum size of 15 billion Danish Kroner.